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Background: MicroRNAs (miRNAs) have recently been shown to play important roles in development of the
immune system and in fine-tuning of immune responses. Human miR-146 family members are known as
inflammation-inducible miRNAs involved in negative feedback regulation of Toll-like receptor (TLR) signalling.
Dysregulation of the miR-146 family has often been linked to inflammatory diseases and malignancies. This study
reports on miR-146a and miR-146b as infection-inducible miRNAs in zebrafish, which has emerged as a model
species for human disease.
Results: Using a custom-designed microarray platform for miRNA expression we found that both members of the
zebrafish miR-146 family, miR-146a and miR-146b, were commonly induced by infection of zebrafish embryos with
Salmonella typhimurium and by infection of adult fish with Mycobacterium marinum. The induction of these miRNAs
was confirmed by Taqman miRNA assays. Subsequently, we used zebrafish embryos, in which adaptive immunity is
not yet active, as an in vivo system to investigate the role of miR-146 in the innate immune response to
S. typhimurium infection. Knockdown of traf6 and use of myd88 mutants demonstrated that the induction of miR-146a
and miR-146b by S. typhimurium infection was affected by disruption of the MyD88-Traf6 pathway that mediates
transduction of TLR signals and cytokine responses. In turn, knockdown of miR-146 itself had no major effects on the
expression of known targets of MyD88-Traf6 signalling. Instead, RNA sequencing analysis showed that miR-146
knockdown led to an increased induction of six members of the apolipoprotein gene family in S. typhimurium-infected
embryos.
Conclusion: Based on microarray analysis and Taqman miRNA assays we conclude that members of the miR-146
family, which is highly conserved between fish and human, are induced by bacterial infection in zebrafish in a MyD88
and Traf6 dependent manner. The combined knockdown of miR-146a and miR-146b in zebrafish embryos infected
with S. typhimurium had no major effect on the expression of pro-inflammatory genes and transcription factors known
to be downstream of the MyD88-Traf6 pathway. In contrast, apolipoprotein-mediated lipid transport emerged as an
infection-inducible pathway under miR-146 knockdown conditions, suggesting a possible function of miR-146 in
regulating lipid metabolism during inflammation.
Keywords: MicroRNA, miR-146, Innate immunity, Infection, Salmonella typhimurium, Mycobacterium marinum, MyD88,
Traf6, Apolipoproteins, Zebrafish* Correspondence: a.h.meijer@biology.leidenuniv.nl
†Equal contributors
1Institute of Biology, Leiden University, Einsteinweg 55, 2333 CC Leiden, The
Netherlands
Full list of author information is available at the end of the article
© 2013 Ordas et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Ordas et al. BMC Genomics 2013, 14:696 Page 2 of 15
http://www.biomedcentral.com/1471-2164/14/696Background
Timely activation as well as termination of inflammatory
responses is essential for proper functioning of the
immune system. A balanced output of the vertebrate
immune response is dependent on several regulatory
mechanisms, in which microRNAs (miRNAs) have recently
emerged as new players with critical importance [1]. Several
human diseases, including cancer, autoimmune diseases,
and chronic inflammatory disorders, have been associated
with dysregulation of miRNA expression both in a positive
or negative regulatory manner [1-5]. MiRNAs are evo-
lutionary conserved, genome-encoded small RNAs (~22
nucleotides) that down-regulate gene expression at the
post-transcriptional level by either translational repression
or by mRNA degradation through binding to the 3′-UTR
of their target mRNAs [6]. MiRNAs were found to have
roles in a diverse range of processes ranging from develop-
ment, cellular differentiation, hematopoiesis, apoptosis, and
growth, to the functioning of the immune system [7-10].
The role of host miRNAs in bacterial infections has
been addressed in several previous studies. MiRNAs were
observed to be differentially regulated by Toll-like re-
ceptor (TLR)-mediated recognition of bacterial molecules.
For instance, lipopolysaccharide (LPS) stimulation of
TLR4 and downstream NFκB activity induced miR-146,
miR-147, and miR-155 [11-13]. Mice deficient in miR-155
could not be protected by vaccination against Salmonella
typhimurium infection and showed strong defects in
T-cell cytokine production [14]. In another study, Salmon-
ella typhimurium infection was found to induce rapid
down-regulation of let-7 miRNA family members in
macrophages, thereby leading to an upregulation of let-7
targets, the IL-6 and IL-10 cytokines [15]. IL-10 produc-
tion in LPS-stimulated macrophages was also found to be
regulated by miR-98 [16]. Furthermore, miR-29 was found
to suppress immune responses to Listeria monocytogenes
and Mycobacterium tuberculosis by targeting IFN-γ [17].
The LPS-inducible miR-146 family comprises two
members in human, miR-146a and miR-146b, which are
transcribed from different genes on chromosome 5 and
10, respectively [18]. They have the same seed sequence
(i.e. the sequence essential for the binding of the miRNA
to its mRNA target) and differ in their mature sequence
by only two nucleotides at the 3′end. Dysregulation of
miR-146a and miR-146b has been observed in many
types of malignant tumors and several studies implicate
these miRNAs as metastasis suppressors [18-23].
MiR-146a has also been implicated in different auto-
immune diseases, including systemic lupus erythe-
matosus, rheumatoid arthritis and Sjögren’s syndrome
[24,25]. The first indication of the role of miR-146a/b in
innate immunity came from work of Taganov et al. [11],
showing increased expression of these miRNAs in the
human monocytic THP-1 cell line when triggered byLPS. Promoter analysis revealed that induction of the
miR-146a gene by LPS, TNFα, and IL-1 is mediated by
the NFκB transcription factor [11]. In addition, 3′-UTR
luciferase reporter assays demonstrated that the TLR
signalling intermediates IRAK1 and TRAF6 are poten-
tial targets of miR-146a and miR-146b [11]. These data
suggested that the miR-146 miRNAs function in a ne-
gative feedback pathway of TLR and cytokine signalling
by targeting IRAK1 and TRAF6 mRNAs for down-
regulation, a conclusion supported by recent analysis of
miR-146a knockout mice [26]. MiR-146a has also been
shown to function as a negative regulator of interferon
(IFN) signalling by targeting the IRF5 and STAT-1
transcription factors [27] and to control the resolution
of T-cell responses in mice [28].
The zebrafish provides a useful model to study innate
immunity, which is the primary line of defence against
infections during the first few weeks of development,
when functional adaptive immunity is not yet present
[29,30]. The zebrafish model combines an efficient gen-
etic toolbox with excellent possibilities for high reso-
lution imaging of host-microbe interactions at the early
life stages (embryos and larvae), when zebrafish are
transparent [29,30]. Many zebrafish infection models for
bacterial pathogens have recently been developed, among
which the S. typhimurium and M. marinum models are
the best characterized [29]. The major signalling pathways
of the innate immune system are conserved within all ver-
tebrates [31] and the repertoire of zebrafish miRNAs is
well described [32,33]. Since miRNAs are strongly con-
served among all vertebrates, the advantages of the
zebrafish model organism may be exploited to elucidate
miRNA functions in the vertebrate host response to bac-
terial infections. As in mammals, the zebrafish miR-146
family has two members, named dre-miR-146a and dre-
miR-146b, which are present within genes located on
chromosome 13 and 21, respectively. The IRAK1 and
TRAF6 homologs of both zebrafish and human contain
putative target sites for miR-146 in their 3′-UTRs,
suggesting that miR-146 feedback control of TLR signal-
ling is evolutionary conserved. Here we report on a micro-
array study of miRNA expression, which showed that
miR-146a and miR-146b are commonly induced by infec-
tion of zebrafish embryos with Salmonella typhimurium
and by infection of adult fish with Mycobacterium
marinum. We demonstrate the requirement of the
MyD88-Traf6 pathway for the infection-triggered induc-
tion of miR-146a/b in the zebrafish embryo model. Fur-
thermore, we used morpholino knockdown to suppress
the function of miR-146a and miR-146b and analyzed the
effects of this down-regulation by RNA deep sequencing
(RNAseq) of embryos infected with Salmonella typhi-
murium. While no major effects on known targets of the
MyD88-Traf6 pathway were observed, apolipoprotein-
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inducible pathway under control of miR-146a/b.
Results
Microarray analysis identifies infection-inducible miRNAs
in zebrafish embryos and adults
In order to study the effects of bacterial infection on
miRNA expression profiles in zebrafish we examined
two infection conditions that are known from previous
mRNA transcriptome studies to elicit a strong
proinflammatory immune response: embryos at 8 hours
post infection (hpi) with the S. typhimurium SL1027
strain and adult fish that were in the end stage of disease
at 6 days post infection (dpi) with the M. marinum
Mma20 strain [34,35]. Since embryos rely solely on in-
nate immunity and adults also have adaptive immunity,
the combination of these infection models allows deter-
mining the contribution of the two arms of the immune
system to the induction of miRNAs [29,30]. To quantify
microRNA gene expression profiles we used a custom
designed 8×15 k Agilent zebrafish array. S. typhimurium
infection of one-day old embryos resulted in differential
expression of probes for 15 miRNAs annotated in
miRBase (8 up-regulated, 7 down-regulated), while the
M. marinum-infected adults showed differential expres-
sion of probes for 57 miRNAs (37 up-regulated, 20
down-regulated) (Figure 1A,B). The miRNA platform
also contains probes for predicted hairpin structures in
the zebrafish genome that might cover additional
miRNAs. A large number of these probes showed differ-
entially expression in the adult infection study (235 up-
regulated, 687 down-regulated), while a much lower
number was affected by infection of embryos (27 up-
regulated, 37 down-regulated). Since the biological re-
levance of these predicted small RNAs is currently
unknown, we did not consider them further in this
study, but focused on the known miRNAs annotated in
miRBase. Several of these miRNAs were commonly up-
regulated by both of the infection conditions, including
miR-21 (mature miRNA and its star sequence), miR-29a,
miR-29b, miR-146a, and miR-146b (Figure 1A). Since
zebrafish embryos have not yet developed adaptive
immunity, it can be concluded that the context of innate
immunity is sufficient to induce the expression of these
miRNAs.
miR-146a and miR-146b are induced during zebrafish
infection with S. typhimurium and M. marinum
MiRNAs of the miR-146 family, which emerged as
infection-inducible miRNAs from the microarray ana-
lysis of embryonic and adult zebrafish, have previously
been linked to the innate immune response in mamma-
lian systems [11]. To confirm the induction of these
miR-146 family members we analyzed miR-146a andmiR-146b expression by TaqMan qPCR analysis. MiR-
222, which showed unaltered expression in the micro-
array study, was used as a control for normalization. In
agreement with the microarray data, miR-146a and b
were specifically induced in embryos at 8 hours post
injection (hpi) with the S. typhimurium SL1027 strain
(Figure 2A). Their induction was also observed in infec-
tions with an attenuated LPS mutant (Ra) strain, SF1592
(Figure 2B). Furthermore, induction of miR-146a and
miR-146b was detected in zebrafish larvae at an
advanced stage of M. marinum Mma20 infection
(Figure 2C). The increase of miR-146a expression in em-
bryos infected with S. typhimurium could be completely
blocked with a morpholino targeting this miRNA
(Figure 2A,B) and this morpholino was effective even up
to the larval stage in reducing M. marinum-induced
miR-146a expression (Figure 2C). The S. typhimurium-
induction of miR-146b in embryos could also be reduced
by morpholino treatment, (Figure 2A,B), but the miR-
146b morpholino was no longer effective at the larval
stage where M. marinum infection was analyzed. In
agreement with the microarray data, induction of miR-
146a and miR-146b was also confirmed in adult
zebrafish infected with M. marinum (Figure 2D).
Infection-inducible expression of miR-146a and miR-146b
is affected by defects in signalling via the MyD88-Traf6
pathway
We used the S. typhimurium embryo infection model to
investigate the dependency of miR-146a and miR-146b
induction on TLR pathway genes. First, we used a previ-
ously described morpholino knockdown model for traf6,
a central intermediate in TLR and TNF receptor signal-
ling [36]. The S. typhimurium-induced expression levels
of miR-146a and miR-146b were significantly lower in traf6
knockdown embryos compared to controls (Figure 3A).
Next, we analyzed miR-146a and miR-146b induction in
a myd88 mutant line [37]. Similar as under traf6 knock-
down conditions, miR-146a and miR-146b were still
infection-inducible in myd88 mutant embryos, but their
expression levels were significantly higher in infected wild
type siblings (Figure 3B). Therefore, we conclude that
miR-146a and miR-146b induction is at least partially
dependent on MyD88 and Traf6.
MiR-146a and miR-146b knockdown does not affect
leukocyte development in zebrafish embryos
Loss of function studies in mice and zebrafish suggested a
possible role of miR-146a in the development of myeloid
cells, in addition to its proposed inhibitory effect on pro-
inflammatory signalling [38]. To investigate the possible
requirement of miR-146a and miR-146b for leukocyte de-
velopment in zebrafish embryos, we designed two different
morpholinos for each miRNA (Additional file 1: Figure S1).
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Figure 1 Microarray analysis of miRNA expression during bacterial infections of zebrafish embryos and adult fish. The Venn diagrams
show the miRBase annotated miRNAs or miRNA star sequences (*) that were up-regulated (A) or down-regulated (B) during infection of zebrafish
embryos with S. typhimurium SL1027 or infection of adult zebrafish with M. marinum Mma20. S. typhimurium infection of embryos was performed
by micro-injection into the caudal vein at 28 hpf and miRNA expression was analyzed at 8 hpi in comparison with control embryos mock-
injected with PBS. Adult zebrafish were infected with M. marinum by intraperitoneal infection and miRNA expression at 6 dpi was compared with
PBS-injected controls.
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TaqMan qPCR analysis, showing that basal expression of
miR-146a and miR-146b (Figure 4A,B) as well as their
infection inducibility (Figure 2A-C) was reduced by
morpholino treatments. Both of the morpholinos designed
for miR-146a (146aMO1 and 146aMO2) did not affect
miR-146b expression, therefore showing specific knock-
down of miR-146a only (Figure 4A,B). However, one of themiR-146b morpholinos (146bMO1) showed knockdown of
both miR-146a and miR146b expression (Figure 4A,B). To
assess leukocyte numbers we performed immunostaining
for the pan-leukocytic marker L-plastin and histochemical
staining for myeloperoxidase (Mpx) activity, a specific
enzyme of neutrophils. First, we analyzed the effect of
combined knockdown of miR-146a and miR-146b at 2 dpf.
No differences were observed between controls and
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Figure 2 Expression of miR-146a and miR-146b is enhanced upon bacterial infections. (A) MiR-146a/b induction in zebrafish embryos by
S. typhimurium. Embryos were injected with S. typhimurium SL1027 (inf) or PBS (mock) at 28 hpf and expression of miR-146a/b was analyzed at 8
hpi. The specificity of miRNA inductions was analyzed with morpholinos (MO) targeting miR-146a (146aMO1) or miR-146b (146bMO1). As a
control a standard control morpholino (scMO) was injected. Data are the mean ± SEM of samples from two independent experiments.
(B) MiR-146a/b induction by the attenuated S. typhimurium LPS mutant (Ra) strain SF1592. Experimental conditions were the same as for infection
with wild type S. typhimurium (miR-146a: single experiment, miR-146b: mean ± SEM of three replicates). (C) MiR-146a/b induction in zebrafish
larvae with M. marinum infection. Embryos were treated with miR-146a/b-targeting or control morpholinos as above, injected with M. marinum
Mma20 (inf) or PBS (mock) at 28 hpf, and expression of miR-146a/b was analyzed in larvae at 6 dpi. Data are the mean ± SEM of samples from
two independent experiments. (D) MiR-146a/b induction in M. marinum-infected zebrafish adults. Adult zebrafish were injected intraperitoneally
with M. marinum Mma20 or mock-injected with PBS and RNA was collected at 6 dpi [35]. Data are the mean ± SEM of three fish per condition.
Expression levels in all experiments were determined by TaqMan qPCR and relative expression levels are shown with the mock control set at 1.
Asterisks indicate significant differences (*, P < 0.05; **, P <0.01; ***, P <0.001) tested by one-way ANOVA analysis with Tukey’s method as post-hoc
test (A-C) or by an unpaired t-test (D).
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(Figure 4C) or Mpx-positive neutrophils (Figure 4D) at this
stage. Since another study had reported an inhibitory effect
of miR-146a knockdown on leukocyte development at 1
dpf [38], we next analyzed the separate effects of miR-146a
and miR-146b knockdown in more detail over a critical
period of leukocyte development from 26 to 32 hpf. During
this period primitive myeloid cells first appear over the yolk
sac, and subsequently invade the head. This first wave of
primitive myeloid cells is rapidly followed by differentiation
of the first erythro-myeloid precursor cells in the caudalblood island region. We performed L-plastin immunostain-
ing with 2 h intervals over the period from 26 to 32 hpf.
The total number of L-plastin-positive leukocytes showed a
similar increase over this time course between control
embryos and embryos injected with 146aMO1, 146aMO2,
or 146bMO1 (Figure 4E-I). 146bMO2 could not be in-
cluded in this quantitative analysis because it affected
embryo development. Nevertheless, L-plastin positive im-
mune cells were still present in 146bMO2 morphants with
mild (Figure 4J) or severe phenotypes (Figure 4K). Based on
these results, we conclude that miR-146a and miR-146b are
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Figure 3 The Traf6-MyD88 pathway is involved in
up-regulation of miR-146a and miR-146b expression levels
upon infection. (A) Traf6-dependent miR-146a/b induction.
Embryos were injected with traf6 morpholino (MO) or a mismatch
morpholino (MM) as a control. Embryos were infected at 28 hpf with
S. typhimurium (inf) or mock-injected with PBS and samples were
collected at 8 hpi. (B) MyD88-dependent miR-146a/b induction.
Mutant (myd88−/−) and wild type siblings (myd88+/+) were infected
with S. typhimurium at 28 hpf followed by sample collection at 8
hpi. Expression levels in both experiments were determined by
TaqMan qPCR and relative expression levels are shown with the
mock control set at 1. Data are the mean ± SEM of three replicate
sample sets. Asterisks indicate significant differences (*, P < 0.05; **,
P <0.01) tested by one-way ANOVA analysis with Tukey’s method as
post-hoc test.
Ordas et al. BMC Genomics 2013, 14:696 Page 6 of 15
http://www.biomedcentral.com/1471-2164/14/696not required for leukocyte differentiation during zebrafish
embryo development.
Combined knockdown of miR-146a and miR-146b does
not have a major effect on pro-inflammatory gene
expression during S. typhimurium infection
In previous work, we observed that knockdown of a nega-
tive regulator of the immune response, the ptpn6 phosphat-
ase gene, resulted in a hyperinduction of pro-inflammatory
gene expression during S. typhimurium infection [39]. Since
miR-146 has also been proposed as a negative regulator of
innate immunity [11], we hypothesized that miR-146knockdown might have a similar effect. To test this hypoth-
esis, we studied the effect of the combination of miR-146a
and miR-146b morpholinos on gene expression in infected
and mock-injected embryos by RNA deep sequencing
(RNAseq) (Figure 5A). First we analyzed the basal expres-
sion differences between morpholino knockdown and the
control in mock-injected embryos. Only 68 genes were af-
fected by knockdown of miR-146a and miR-146b, among
which 5 genes are members of the p53 signalling pathway
(Figure 5B, Additional file 2: Table S1). This might reflect a
non-specific effect of the miR-146 knockdown procedure,
since morpholino effects on the p53 pathway are relatively
common [40]. S. typhimurium infection had a much differ-
ent effect than morpholino treatment (Figure 5B) and
resulted in significant alteration of KEGG pathways related
to the immune response and metabolism (Figure 5C), in
agreement with previous studies [34,36,39,41]. In statistical
comparison between uninfected and infected groups, the
total number of infection-regulated genes was higher in
miR-146 morphants (753 genes) than in control embryos
(574 genes) (Figure 5A, Additional file 3: Table S2).
Direct statistical comparison between the infected control
and morpholino groups also showed a higher number
of infection-regulated genes in miR-146 morphants (118
genes, Figure 5A). However, the only pro-inflammatory
marker that was induced by infection to higher levels
in miR-146 morphants compared with the controls was
the matrix metalloproteinase 9 (mmp9) gene (Additional
file 4: Table S3). RNAseq showed a 1.5-fold higher
infection-induction of this gene in miR-146 morphants,
which was confirmed by qPCR analysis (Additional file 5:
Figure S2). Other pro-inflammatory genes, such as inter-
leukin 1b (il1b), CXCL and CCL family chemokines, and
transcriptional regulators of the immune response were
induced to similar levels in miR-146 morphants and
controls. In conclusion, knockdown of miR-146a and
miR-146b in zebrafish embryos did not have a strong
effect on innate immunity signalling in the first 8 hours of
the response to S. typhimurium infection, despite the
increased expression of these miRNAs during this phase.
Combined knockdown of miR-146a and miR-146b leads
to increased infection-inducibility of apolipoprotein genes
Instead of a significant effect on known innate immune
response genes, the RNAseq analysis revealed a possible
effect on lipid transport pathways in S. typhimurium-
infected miR-146 morphants. Six members of the apolipo-
protein family (Figure 5C) were significantly induced upon
S. typhimurium infection of miR-146 morphants but not in
infected control embryos. To confirm this observation we
performed qPCR analysis for the apolipoprotein gene
family members (Figure 6). Only S. typhimurium-infected
embryos were analyzed, since RNAseq analysis (Figure 5)
showed an effect of miR-146 morpholinos on apolipoprotein
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Figure 4 Knockdown of miR-146a and miR-146b does not affect leukocyte development. Embryos were injected at the 1-cell stage with
morpholinos targeting miR-146a (146aMO1 and 146aMO2) or miR-146b (146bMO1 and 146bMO2) or were injected with standard control
morpholino (scMO). (A, B) Confirmation of morpholino knockdown. Embryos were injected with the indicated morpholinos and RNA was
collected at 2 dpf. Knockdown of miR-146a (A) and miR-146b (B) was confirmed by TaqMan qPCR. This analysis also demonstrated the specificity
of morpholinos 146aMO1, 146aMO2, and 146bMO2 for their respectively target miRNAs, whereas 146bMO1 could not discriminate between the a
and b forms of miR-146. 146bMO2 positively affected miR-146a expression besides blocking miR-146b expression and caused developmental
aberrations (J, K). (C) Quantification of L-plastin-positive leukocytes at 2 dpf. Embryos were injected with the control morpholino (scMO) or with a
combination of 146aMO1 and 146bMO1 (146a/bMOs). L-plastin-labelled cells were counted manually on the left side of each embryo and the
numbers present in the head, on the yolk sac, and in the tail were accumulated (n ≥ 26 embryos per group). (D) Quantification of Mpx-positive
neutrophils at 2dpf. Embryos were injected with the indicated morpholinos. Neutrophils stained for Mpx activity were counted manually as
described for L-plastin immunostaining (n≥ 13 embryos per group). (E) Quantification of L-plastin-positive leukocytes at 26, 28, 30 and 32 hpf.
Embryos were injected with the indicated morpholinos and L-plastin-labelled cells were counted as described above (n≥ 16 embryos per time
point). (F-K) Example fluorescence images of the data shown in (E). The pattern of L-plastin-positive immune cells was comparable between
embryos (32 hpf) injected with scMO (F), 146aMO1 (G), 146aMO2 (H), and 146bMO1 (I). 146bMO2 gave non-specific phenotypes and the
number of immune cells was more variable dependent upon the severity of the phenotype (J, K).
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Figure 5 Effect of combined miR-146a and miR-146b knockdown on the transcriptome response to S. typhimurium infection.
(A) Experimental set-up and DESeq analysis. Embryos treated with 146a/b morpholinos or standard control morpholino were infected with
S. typhimurium or mock-injected with PBS, and subjected to RNAseq at 8 hpi. DESeq was used for pairwise statistical comparison of transcript count
data from the four treatment groups: control/mock (con), control/infected (con St), 146a/bMOs/mock (146MO), and 146a/bMOs/infected (146MO St).
The number of genes up-regulated (↑) or down-regulated (↓) is indicated. (B) Venn diagrams showing the overlap between differentially
expressed gene sets resulting from different DESeq comparisons. Top row: up-regulated genes (↑), bottom row: down-regulated genes (↓).
Venn diagrams (i) and (ii) show that there was little overlap between the morpholino effect (con vs. 146MO) and the effect of infection (con vs.
con St or 146MO vs. 146MO St). Venn diagram (iii) shows strong overlap in how the control and morpholino-treated groups responded to
infection. Venn diagram (iv) shows the comparison between the morpholino effect in the absence (con vs. 146MO) and in the presence
(con St vs. 146MO St) of infection. (C) Enrichment of signalling pathways and processes revealed by gene ontology analysis. KEGG pathway
analysis was performed using DAVID v6.7 (http://david.abcc.ncifcrf.gov) [42]. Pathways linked with innate immunity and metabolism were
significantly enriched by infection in both the control and morpholino treatment groups (Venn diagrams i and ii above). Pathways for p53
signalling and apoptosis were enriched due to 146MO treatment both in the absence and presence of infection (overlap group in Venn
diagram iv). A set of apolipoprotein genes was significantly up-regulated by infection only in the 146MO treatment group (146MO vs. 146MO St
sector of Venn diagram iii and con St vs. 146MO St sector in Venn diagram iv).
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injected controls. Results showed that under conditions of
S. typhimurium infection, the expression levels of genes
apoa1a, apoa4, apoba, apobb, apoc1l, apoeb were between
1.5- and 3- fold higher in miR-146 morphants compared
with control embryos. Therefore, miR-146 miRNAs may beinvolved in fine-tuning of lipid-mediated inflammatory
responses of the zebrafish embryo.
Discussion
By microarray analysis of miRNA expression in zebrafish
we found that miRNAs of the miR-21, miR-29, and miR-
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Figure 6 Increased infection-induction of apolipoprotein gene expression under conditions of combined miR-146a and miR-146b
knockdown. (A-F) Embryos were injected with control morpholino (scMO) or with a combination of 146aMO1 and 146bMO1 (146a/bMOs) and
infected with S. typhimurium as described in Figure 5. Gene expression levels of six apolipoprotein genes, apoa1a (A), apoa4 (B), apoba (C),
apobb (D), apoc1l (E), and apoeb (F), were analyzed by qPCR in two replicate infection experiments (1 and 2) and relative expression levels are
shown with the lowest expression level set at 1. Data are the mean ± SEM of triplicate qPCR measurements. Asterisks indicate significant
differences (*, P < 0.05; **, P <0.01) determined by an un-paired t-test.
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bryos with S. typhimurium and by infection of adult fish
with M. marinum. The induction of members of the
miR-21, miR-29, and miR-146 families was in line with
earlier microarray studies, which reported these along
with some other miRNAs, like miR-9, miR-132, miR-147,
and miR-155 as infection-inducible [13,26,43,44]. We did
not detect altered expression of miR-122 and miR-194,
which were found to be inducible during zebrafish in-
fection with Vibrio harveyi [45]. We focused our study
on the miR-146 family, which is strongly linked with
immune-related diseases in human. We used zebrafish
at the embryo stage, when only innate immunity is
functional, as an in vivo model to study the role of
miR-146 during bacterial infection.The miR-146a and miR-146b sequences are conserved
between zebrafish and human as well as target sites in
the 3′-UTR of mRNAs of innate immune pathway genes
such as IRAK1 and TRAF6, which are experimentally
validated targets of miR-146 [11,26]. Therefore, miR-
146a and miR-146b of zebrafish may function in feed-
back control of TLR signalling, like the human and mur-
ine counterparts [11,26]. To study the pathway by which
miR-146 expression is induced in zebrafish embryos
upon infection we used embryos in which TLR signalling
was disrupted by morpholino knockdown of traf6 or by
mutation of myd88. The induction levels of miR-146a
and miR-146b upon S. typhimurium infection were re-
duced under conditions of traf6 or myd88 deficiency,
but induction was not completely abolished. In the case
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expression may be due to a partial morpholino knock-
down effect. We have previously shown that mutation of
myd88 strongly affects the innate immune response to
S. typhimurium infection, but that innate immune genes
can still be induced to lower levels in the absence
of functional MyD88 [37]. Therefore, it is likely that
both the MyD88-Traf6-dependent pathway and parallel
MyD88-independent signalling routes contribute to the
infection-induced expression of miR-146.
A recent study by Ghani et al. [38] suggested miR-
146a to be required for myeloid cell differentiation in
mouse and zebrafish. They reported that miR-146a
morpholino knockdown caused an almost complete ab-
sence of myeloid cells in zebrafish embryos at 1 dpf.
However, in our analysis we found no evidence for an
inhibitory effect of miR-146 deficiency on myeloid cell
development. We used two morpholinos for miR-146a
(one of which was the same as a miR-146a morpholino
used by Ghani et al. [38]), and verified the knockdown
effect by TaqMan qPCR, which showed that the mor-
pholinos effectively inhibited both the basal expression
and the infection-induced expression. By immunostain-
ing for the pan-leukocytic marker L-plastin we detected
no differences in myeloid cell development between
miR-146a morphants and controls over an elaborate
time course between 26 and 32 hpf, which comprises
the critical embryonic stages when myeloid cells differ-
entiate and enter the circulation. Furthermore, no effect
on neutrophil differentiation at 2 dpf was detected. For
miR-146b we also did not observe an effect on leukocyte
development with two different morpholinos targeting
this miRNA. Ghani et al. [38] used mRNA in situ
hybridization for detection of L-plastin, which might
explain the difference with our study in which we used a
sensitive immunolabelling method, which is widely used for
detection and quantification of myeloid cells in zebrafish
embryos [46,47]. Our conclusion that myeloid development
in zebrafish embryos is not inhibited by miR-146a or miR-
146b deficiencies is in line with the phenotype of miR-146a
knockout mice, which also were not impaired in myeloid
differentiation but in fact showed hyperproliferation of
myeloid cells leading to autoimmunity [26].
Knockout mice of miR-146a are hyperresponsive to
LPS, showing increased up-regulation of pro-inflammatory
cytokines, such as TNF and IL-6 [26]. We used S. typhi-
murium infection of zebrafish embryos, which results in
strong pro-inflammatory gene induction, to analyze the
knockdown effect of miR-146a and miR146b by RNAseq
analysis. We used a combination of morpholinos against
miR-146a and miR-146b in the RNAseq study to avoid that
the two miRNAs might compensate for each other’s loss-of
-function, as their mature sequences differ only by two
nucleotides. Several genes in the p53 pathway, includingp53 itself, were up-regulated in miR-146 morphants as
compared to controls under infected as well as non-
infected conditions. This might be attributed to the well
known off target effects of morpholino oligonucleotides
[40]. However, as miR-146 has been frequently linked with
cancer, a direct effect on the p53 pathway cannot be ex-
cluded [18,48,49]. In fact, one of the p53 pathway genes up-
regulated by miR-146 knockdown, cdkn1a (p21), is an ex-
perimentally validated target of miR-146a in human [50].
In total we found 73 genes which were significantly
up-regulated in miR-146 infection as compared to control
infection. Besides cdkn1a, only one other gene, fibrinogen
beta chain (fgb), showed an overlap with the predicted
targets of zebrafish miR-146a and miR-146b in miRBase.
Fibrinogen has roles in cell adhesion, hematopoiesis, and in
coagulation and complement cascades associated with
primary defence against bacterial infections [51]. Expression
levels of other known targets of miR-146 involved in innate
immunity, such as irak1, traf6, irf5 and stat1, were not
affected, but this was not unexpected since miRNAs can
act by translational inhibition.
The matrix metalloproteinase gene mmp9 is one of
the most strongly induced pro-inflammatory markers in
S. typhimurium infection [34]. The combined morpho-
lino knockdown of miR-146a and miR-146b led to slightly
increased induction of this gene during S. typhimurium
infection; however, this induction of mmp9 was not
accompanied by a general hyperinduction of other pro-
inflammatory markers in the RNAseq analysis. MMP9
is not a predicted target gene of miR-146 in human or
zebrafish, but human MMP9 was found to be down-
regulated upon miR-146a/b overexpression in MDA-
MB-231 breast cancer cells and in THP-1 macrophages
[20,52]. This down-regulation was suggested to occur
via TLR-mediated and NFκB-dependent pathways rather
than by direct targeting of MMP9 [20,52]. Likewise, the
induction of zebrafish mmp9 under miR-146a/b knock-
down conditions might be an indirect consequence of
effects on upstream signalling proteins. In agreement,
we have previously shown that mmp9 induction by
S. typhimurium infection is mediated by Traf6, which is
a known target of miR-146 [11,26,36].
By targeting components of TLR signalling, miR-146
has been shown to function as a negative regulator of the
innate immune response in mammals [11,26]. However, in
our study of S. typhimurium infection in zebrafish em-
bryos, miR-146 knockdown did not have a strong impact
on the induction of proinflammatory genes. Notably, the
effect of miR-146 knockdown was minor in comparison
with knockdown analysis of ptpn6, which encodes a SH2-
domain phosphatase that functions as a negative regulator
of innate immunity [53,54]. In the same experimental set-
up, S. typhimurium infection of zebrafish embryos after
knockdown of ptpn6 resulted in hyperinduction of mmp9
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genes, and transcriptional regulators of the immune re-
sponse [39], while in the case of miR-146 knockdown only
mmp9 was slightly higher induced. Furthermore, hype-
rinflammation in ptpn6 morphants impaired control of
S. typhimurium infection [39], while miR-146 knockdown
had no such effect (data not shown). These results support
that in the early response of zebrafish embryos to
S. typhimurium infection Ptpn6 functions as a much
stronger negative feedback regulator than miR-146. This
would be consistent with the idea that miRNAs function
in a subtle fine-tuning of the immune response [1].
While the overall knockdown effect observed in our
RNAseq analysis was relatively minor, apolipoprotein-
mediated lipid transport emerged as an infection-inducible
pathway under miR-146 knockdown conditions. Numerous
studies have linked apolipoproteins to immunoregulation
and host defence [55-57]. MiR-146a has been suggested
to be involved in negative regulation of oxidized low-
density lipoprotein-(LDL) accumulation in macrophages
[52]. Lipid accumulation in macrophages is associated with
the inflammatory processes that lead to atherosclerosis.
The expression of miR-146a was found to be down-
regulated when THP-1 macrophages were stimulated with
oxidized LDL. Furthermore, miR-146 overexpression re-
duced intracellular LDL cholesterol content and secretion
of IL6, IL8, and MMP9 via TLR4-mediated signalling. A
similar effect on LDL accumulation was observed by silen-
cing miR-155, another important miRNA regulator of im-
mune processes [58]. Based on its regulatory role in lipid
accumulation miR-146a has been proposed as a potential
therapeutic candidate for atherosclerosis treatment [52].
Our results support the inhibitory function of miR-146 in
lipid-mediated inflammatory responses and the proposed
application as a therapeutic target.
Conclusion
Recent studies have demonstrated the involvement of
miRNAs in immune processes and their link to inflam-
matory disorders and have increased interest to find the
molecular pathways responsible for miRNA action [1].
MiR-146 has been recognized as a modulator of the
innate and adaptive immune responses in mammals
[11,26,28]. In a microarray analysis of miRNA expression
in zebrafish, both of the miR-146 family members, miR-
146a and miR-146b, were found to be inducible by
S. typhimurium and M. marinum infections. The miR-
146 family members were commonly induced during
infections of embryos and adult fish, along with miRNAs
of the miR-21 and miR-29 families, which also have been
implicated in immunity and infection. The induction of
these miRNAs in embryo infection models links them
specifically with the innate immune response, as adaptive
immunity is not yet functional at early developmentalstages. We exploited the embryo model as an in vivo
system to investigate the role of miR-146 in the innate
immune response to S. typhimurium infection. Induction
of miR-146a and miR-146b by infection was shown to be
affected by deficiencies in Traf6 and Myd88, which are
central intermediates of Toll-like receptor and cytokine
signalling pathways. MiR-146 has previously been impli-
cated in negative feed-back regulation of these pathways
[11,26], similar to a number of signalling proteins, in-
cluding the protein-tyrosine phosphatase Ptpn6 [53,54].
However, whereas knockdown of the ptpn6 gene caused
hyperinflammation in zebrafish embryos [39], knockdown
of miR-146 in the S. typhimurium embryo infection model
had no major effect on pro-inflammatory gene expression
or on the expression of transcriptional regulators and sig-
nal transduction components of known immune response
mediators. In contrast, several members of the apolipo-
protein gene family (apoa1a, apoa4, apoba, apobb, apoc1l,
and apoeb) were infection inducible only under miR-146
knockdown conditions. The apolipoprotein family has been
linked to immunoregulation and host defence in many
studies [55,56]. Consistent with a previous report proposing
miR-146a as a negative regulator of LDL accumulation
in human macrophages and a therapeutic target for
atherosclerosis treatment [52], our results suggest a
possible function of miR-146 in regulating apolipoprotein-
mediated lipid transport under the inflammatory condi-
tions of S. typhimurium infection.
Methods
Zebrafish husbandry
Zebrafish were handled in compliance with the local animal
welfare regulations and maintained according to standard
protocols (zfin.org). The breeding of adult fish was ap-
proved by the local animal welfare committee (DEC) of
Leiden University. All protocols adhered to the inter-
national guidelines specified by the EU Animal Protection
Directive 2010/63/EU. Embryos from the zebrafish AB/TL
line were used for the infection experiments. In addition,
an infection experiment was performed using embryos
from a myd88 mutant line and wild type siblings as a con-
trol [37]. Embryos were grown at 28–30°C in egg water
(60 μg/ml Instant Ocean sea salts). For the duration of bac-
terial injections embryos were kept under anesthesia in egg
water containing 200 μg/mL tricaine (Sigma-Aldrich).
Significance cut-offs for DEseq analysis were set at: absolute
fold change ≥1.5 and adjusted P-value ≤ 0.1. Embryos used
for immunostaining and Myeloperoxidase (Mpx) assay
were kept in egg water containing 0.003% 1-phenyl-2-thio-
urea (Sigma-Aldrich) to prevent melanization.
Infection experiments
S. typhimurium infections were performed using strain
SL1027 and its isogenic LPS Ra mutant derivative
Ordas et al. BMC Genomics 2013, 14:696 Page 12 of 15
http://www.biomedcentral.com/1471-2164/14/696SF1592, carrying the DsRed expression vector, pGMDs3
[59]. M. marinum infections were performed with strain
Mma20 expressing mCherry in pSMT3 vector [35,60].
Bacteria were grown and prepared for injections as pre-
viously described and microinjected into the caudal vein
of embryos at 28 hours post fertilization (hpf ), using a
dose of 200–250 CFUs of S. typhimurium or 100 CFU
of M. marinum per embryo [61]. As a control, embryos
were mock-injected with PBS. After injections, embryos
were transferred to fresh egg water and incubated at
28°C. Adult zebrafish infected with the M. marinum
Mma20 strain (6 dpi) and PBS-injected control fish
were from a previous study [35].
RNA/miRNA isolation and quality check
Embryos were snap frozen in liquid nitrogen and kept
at −80°C. Adult zebrafish were homogenized in liquid
nitrogen and kept in portions of 50–100 μg of powdered
tissue at −80°C. Total RNA was isolated from frozen
embryos or tissue homogenates using the miRNeasy
Mini kit (Qiagen) with an on-column DNA purification
with RNase Free DNase set (Qiagen). RNA quality of
samples for RNAseq analysis was checked with an
Agilent Bioanalyzer 2100 using the RNA 6000 Nano
series Kit (Agilent, Santa Clara, CA, USA). All samples
had a RNA integrity value (RIN) of 10.
Microarray analysis of miRNAs
Custom-designed 8×15 k microarray slides were ordered
from Agilent Technologies. The 15 k custom design was
obtained from Edwin Cuppen and Eugene Berezikov
(Hubrecht Institute, Utrecht, The Netherlands) and has
been submitted into the Gene Expression Omnibus
(GEO) database (GPL 15403). The 15 k design contained
a duplicate of 7604 probes of 60-oligonucleotide length.
The probes consisted of 2x22 nucleotide sequences
antisense to mature miRNAs separated by a spacer of 8
nucleotides (CGATCTTT) and with a second spacer
with the same sequence at the end. From 7604 probes 546
were designed for left (5′) and right (3′) arms of the hair-
pins of zebrafish miRNAs that are known in miRBase,
while the remainder 7058 probes corresponded to pre-
dicted hairpin structures in the zebrafish genome that
might include additional miRNAs. Total RNA, including
microRNA, was extracted from pools of 20–30 embryos
or from individual adult fish using the miRNeasy Mini
Kit® (Qiagen). Three biological replicates were used for
each condition. RNA labelling was carried out with the
miRCURY™ LNA microRNA, Hy3™/Hy5™ Power Label-
ling kit (Exiqon) using 1 μg of total RNA according to
the manufacturer’s instructions. RNA samples from
infected embryos or adults were labelled with Hy3 and
hybridized against Hy5-labelled RNA samples from
PBS-injected controls. The dual color hybridization ofthe microarray chips was performed according to
Agilent protocol GE2_105_Jan09 (www.Agilent.com)
for two-color microarray-based gene expression analysis
except that hybridization and washing was performed at
37°C. The arrays were scanned with DNA Microarray
Scanner G2505B from Agilent Technologies. The arrays
were scanned twice with 10% PMT and 100% PMT laser
power. Microarray data was processed from raw data
image files with Feature Extraction Software 9.5.3.1
(Agilent Technologies). The XDR function was used to
extend the dynamic range. Processed data were subse-
quently imported into Rosetta Resolver 7.1 (Rosetta
Biosoftware, Seattle, Washington) and subjected to de-
fault ratio error modelling. Ratio results from control
vs. infected replicates were combined using the default
ratio experiment builder. Significance cut-offs for the
ratios of infected versus control were set at 1.5-fold
change at P ≤ 10 − 4. Significance cut-offs for DEseq
analysis were set at: absolute fold change ≥1.5 and ad-
justed P-value ≤ 0.1. The raw data have been submitted
to GEO under accession number GSE45410.
Morpholino knockdown
Morpholino oligonucleotides (GeneTools) were diluted
to the desired concentration in 1× Danieau buffer
(58 mM NaCl, 0.7 mM KCl, 0.4 mM MgSO4, 0.6 mM
Ca(NO3)2, 5.0 mM HEPES; pH 7.6) containing 1% phe-
nol red (Sigma-Aldrich) and approximately 1 nl was
injected at the 1–2 cell stage using a Femtojet injector
(Eppendorf). For knockdown of miR-146a and miR-146b
two morpholinos were used against each of them. The
first morpholino for miR-146a (146aMO1: 5′ACCATC-
TATGGAATTCAGTTCTCAG3′) targets the miRNA
guide strand and the second morpholino (146aMO2:
5′GAGCCCAUAGAUGAACUUUUCAUGA3′) over-
laps with the star strand and the dicer cleavage site on
the star strand (Additional file 1: Figure S1A). For
miR-146b, the first morpholino (146bMO1: 5′GACAC-
CCTTGGAATTCAGTTCTCAA3′) also targets the guide
strand, and the second morpholino (146bMO2: 5′CGTGG-
GCTGAATATAAAGCAGACAC3′) overlaps with both
dicer cleavage sites and part of the star strand (Additional
file 1: Figure S1B). All miR-146 morpholinos could be
used at a concentration of 0.75 mM without causing mor-
phological defects, except146b-MO2, which was highly
toxic. Another morpholino design for miR-146b was not
recommended by GeneTools. For traf6 knockdown we
used a previously described morpholino [36]. As a control
the standard control morpholino (scMO) from GeneTools
was used as previously described [39].
Detection of leukocytes
Embryos were fixed in 4% paraformaldehyde (PFA) in
PBS. Immunofluorescence detection of leukocytes was
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against L-plastin [57] and Alexa Fluor 488 goat anti-
rabbit IgG secondary Ab (Molecular Probes), as previ-
ously described [62]. Fluorescence images were taken
with a Leica MZ16FA stereo fluorescence microscope
equipped with a DFC420C digital color camera. Histo-
chemical detection of neutrophils was performed by
Mpx activity staining using the Peroxidase Leukocyte Kit
(Sigma-Aldrich) as previously described [62].
RNAseq analysis
For RNAseq analysis, embryos were injected with a
combination of 146aMO1 and 146bMO1, or with the
scMO. Subsequently, at 28 hpf they were infected with
S. typhimurium or mock-injected with PBS, and RNA was
isolated from pools of at least 50 embryos at 8 hours post
injection (hpi). Two independent experiments were per-
formed for RNAseq analysis of biological duplicates. A
total of 3 μg of RNA was used to make RNAseq libraries
using the Illumina TruSeq RNA Sample Preparation Kit
v2 (Illumina Inc., San Diego, USA). In the manufacturer’s
instructions two modifications were made. In the adapter
ligation step 1 μl instead of 2.5 μl adapter was used. In the
library size selection step the library fragments were iso-
lated with a double Ampure XP purification with a 0.7×
beads to library ratio. The resulting mRNA-Seq library
was sequenced using an Illumina HiSeq2000 instrument
according to the manufacturer’s description with a read
length of 2 × 50 nucleotides. Image analysis and base call-
ing was done by the Illumina HCS version 1.15.1. Se-
quence reads were quality trimmed using the quality_trim
module in the CLCbio Assembly Cell v4.0.6. Filtered reads
were mapped to Ensembl transcripts (Zv9_63) using the
ref_assemble_short module in the CLCbio Assembly
Cell v4.0.6. Accumulation of transcripts to Ensembl
genes was done by first converting the mapping files
to a table with the assembly_table module in the
CLCbio Assembly Cell v4.0.6. Secondly a custom
script was used that sums all reads belonging to a
transcript. Non-uniquely mapped reads were divided
between transcripts according to their ratio of
uniquely mapped reads. Finally, read counts of tran-
scripts belonging to the same gene were summed
to obtain count data at Ensembl gene level. Fold-
change and differential expression significance values
were calculated from gene level read counts using
the DESeq package (version 1.8.3) available in
Bioconductor (version 2.10). DESeq utilizes a negative
binomial distribution for modeling read counts per
gene and implements a method for normalizing the
counts [63]. Significance cut-offs for DEseq analysis
were set at: absolute fold change ≥1.5 and adjusted P-
value ≤ 0.1. The raw data have been submitted to
GEO under accession number GSE45410.Quantitative RT-PCR analysis
For quantification of miR-146a/b expression levels, RT-
PCR reactions were performed using a TaqMan microRNA
reverse transcription kit (Applied Biosystem) according to
the manufacturer’s instructions. Briefly, 10 ng of total RNA
was reverse transcribed using 5× RT primers (Custom
TaqMan small RNA Assay-Applied Biosystem) in a total re-
action volume of 15 μl. Reactions were kept on ice for
5 min and then were transferred to the thermal cycler for
incubations at 16°C and 42°C for 30 min each, followed by
an incubation at 85°C for 5 min. Quantitative RT-PCR with
0.665 μl cDNA input per reaction was performed using a
Custom TaqMan small RNA Assay for each miRNA and a
TaqMan Universal PCR Master Mix (Applied Biosystem) in
a total of 10 μl per reaction. Cycle threshold values were
calculated under the parameters of 40 cycles of 10 min at
95°C, 15 sec at 95°C and 60 sec at 60°C. All reactions were
performed in triplicate. For normalization, miR-222, which
showed no changes in response to bacterial challenge, was
taken as reference. Results were analyzed using the ΔΔCt
method. Quantification of mmp9 and apolipoprotein gene
expression was performed as previously described [39],
using the ppial gene for normalization and the primers in
Additional file 6: Table S4.
Availability of supporting data
The data sets supporting the results of this article are
available in the Gene Expression Omnibus repository
under accession number GSE45410 (http://www.ncbi.
nlm.nih.gov/geo/query/acc.cgi?acc=GSE45410).
Additional files
Additional file 1: Figure S1. Target sites of miR-146a and miR-146b
morpholinos on their respective miRNAs. The stem-loop sequences of
the zebrafish miR-146a and miR-146b homologs, dre-miR-146a (A) and
dre-miR-146b (B) are shown with the miRNA guide strand in lower case.
The activity of miRNAs can be blocked using morpholinos
complementary to the miRNA guide strand or to the Drosha or Dicer
nucleolytic processing sites of the primary miRNA or pre-miRNA (www.
gene-tools.com). Regions targeted by the morpholinos are indicated in
blue (146aMO1 and 146bMO1) or yellow (146aMO2 and 146bMO2), and
overlap between two morpholino regions is shown in green.
Additional file 2: Table S1. Effect of miR-146a and miR-146b
knockdown on gene expression in the absence of infection. The table
lists the genes showing significantly up- or down-regulated expression
under knockdown conditions of miR-146a and miR-146b in comparison
with control embryos (experimental set-up shown in Figure 5A).
Significance cut-offs were: -1.5≤ fold change ≤ 1.5 and adjusted P-value
≤ 0.1 in statistical analysis with DESeq. Some genes were undetectable in
one of the samples, resulting in an infinite fold change, which is
indicated in the table as Inf or Inf down for up- and down-regulated
genes, respectively. Genes are annotated by Ensembl ID, description and
gene symbol.
Additional file 3: Table S2. Effect of S. typhimurium infection on gene
expression in control embryos and under conditions of miR-146a and
miR-146b knockdown. The table lists the genes showing significantly
up- or down-regulated expression due to S. typhimurium infection in
embryos injected with a standard control morpholino or with a
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(experimental set-up shown in Figure 5A). Significance cut-offs
were: -1.5 ≤ fold change ≤ 1.5 and adjusted P-value ≤ 0.1 in statistical
analysis with DESeq. Significant values are marked yellow. Some genes
were undetectable in one of the samples, resulting in an infinite fold
change, which is indicated in the table as Inf or Inf down for up- and
down-regulated genes respectively. Genes are annotated by Ensembl ID,
description and gene symbol.
Additional file 4: Table S3. Effect of miR-146a and miR-146b
knockdown on gene expression during S. typhimurium infection. The table
lists the genes showing significantly up- or down-regulated expression in
S. typhimurium-infected embryos under knockdown conditions of miR-146a
and miR-146b in comparison with S. typhimurium-infected control embryos
(experimental set-up shown in Figure 5A). Significance cut-offs were: -1.5≤
fold change≤ 1.5 and adjusted P-value≤ 0.1 in statistical analysis with
DESeq. Some genes were undetectable in one of the samples, resulting in
an infinite fold change, which is indicated in the table as Inf or Inf down for
up- and down-regulated genes, respectively. Genes are annotated by
Ensembl ID, description and gene symbol.
Additional file 5: Figure S2. Increased mmp9 expression in
S. typhimurium infection under knockdown conditions of miR-146a and
miR-146b. Embryos were injected with control morpholino (scMO) or
with a combination of 146aMO1 and 146bMO1 (146a/bMOs) and
infected with S. typhimurium or mock-injected with PBS as described in
Figure 5. Gene expression of mmp9 was analyzed by qPCR and relative
expression levels are shown with the mock control set at 1. The mmp9
induction level after S. typhimurium infection was significantly higher in
miR-146a/miR-146b morphants than in control embryos, consistent with
the results of RNAseq analysis (Additional file 4: Table S3). Data are the
mean ± SEM of samples from two independent experiments. Asterisks
indicate significant differences (*, P < 0.05; **, P <0.01) tested by one-way
ANOVA analysis with Tukey’s method as post-hoc test.
Additional file 6: Table S4. Primer sequences for qPCR analysis of
apolipoprotein genes. Forward and reverse primer sequences for
apolipoprotein genes A-1a, A-IV, Ba, Bb, C1-like, and Eb.Competing interests
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